ChAd3-EBO-Z

· National Institute of Allergy and Infectious Diseases (NIAID)

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ChAd3-EBO-Z, covering 2016-12-08 to 2021-06-02. Get the full timeline:

Most recent: Clinical Trial Update: A Trial to Evaluate the Safety and Systems Biology Response of Ebolavirus Zaire Vaccine (ChAd3-EBO-Z) [Phase 1]